197 related articles for article (PubMed ID: 21677873)
1. PDGF-B Can sustain self-renewal and tumorigenicity of experimental glioma-derived cancer-initiating cells by preventing oligodendrocyte differentiation.
Jiang Y; Boije M; Westermark B; Uhrbom L
Neoplasia; 2011 Jun; 13(6):492-503. PubMed ID: 21677873
[TBL] [Abstract][Full Text] [Related]
2. Glioma initiating cells contribute to malignant transformation of host glial cells during tumor tissue remodeling via PDGF signaling.
Chen Y; Wang Z; Dai X; Fei X; Shen Y; Zhang M; Wang A; Li X; Wang Z; Huang Q; Dong J
Cancer Lett; 2015 Sep; 365(2):174-81. PubMed ID: 26049020
[TBL] [Abstract][Full Text] [Related]
3. Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4.
Yi L; Zhou X; Li T; Liu P; Hai L; Tong L; Ma H; Tao Z; Xie Y; Zhang C; Yu S; Yang X
J Exp Clin Cancer Res; 2019 Aug; 38(1):339. PubMed ID: 31382985
[TBL] [Abstract][Full Text] [Related]
4. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.
Dai C; Celestino JC; Okada Y; Louis DN; Fuller GN; Holland EC
Genes Dev; 2001 Aug; 15(15):1913-25. PubMed ID: 11485986
[TBL] [Abstract][Full Text] [Related]
5. Paired related homeobox 1 transactivates dopamine D2 receptor to maintain propagation and tumorigenicity of glioma-initiating cells.
Li Y; Wang W; Wang F; Wu Q; Li W; Zhong X; Tian K; Zeng T; Gao L; Liu Y; Li S; Jiang X; Du G; Zhou Y
J Mol Cell Biol; 2017 Aug; 9(4):302-314. PubMed ID: 28486630
[TBL] [Abstract][Full Text] [Related]
6. miRNA-21 is developmentally regulated in mouse brain and is co-expressed with SOX2 in glioma.
Põlajeva J; Swartling FJ; Jiang Y; Singh U; Pietras K; Uhrbom L; Westermark B; Roswall P
BMC Cancer; 2012 Aug; 12():378. PubMed ID: 22931209
[TBL] [Abstract][Full Text] [Related]
7. Pivotal role for ROS activation of p38 MAPK in the control of differentiation and tumor-initiating capacity of glioma-initiating cells.
Sato A; Okada M; Shibuya K; Watanabe E; Seino S; Narita Y; Shibui S; Kayama T; Kitanaka C
Stem Cell Res; 2014 Jan; 12(1):119-31. PubMed ID: 24185179
[TBL] [Abstract][Full Text] [Related]
8. PDGF Engages an E2F-USP1 Signaling Pathway to Support ID2-Mediated Survival of Proneural Glioma Cells.
Rahme GJ; Zhang Z; Young AL; Cheng C; Bivona EJ; Fiering SN; Hitoshi Y; Israel MA
Cancer Res; 2016 May; 76(10):2964-76. PubMed ID: 26951930
[TBL] [Abstract][Full Text] [Related]
9. Id2 mediates oligodendrocyte precursor cell maturation arrest and is tumorigenic in a PDGF-rich microenvironment.
Havrda MC; Paolella BR; Ran C; Jering KS; Wray CM; Sullivan JM; Nailor A; Hitoshi Y; Israel MA
Cancer Res; 2014 Mar; 74(6):1822-32. PubMed ID: 24425046
[TBL] [Abstract][Full Text] [Related]
10. Oligodendrocyte progenitor cells can act as cell of origin for experimental glioma.
Lindberg N; Kastemar M; Olofsson T; Smits A; Uhrbom L
Oncogene; 2009 Jun; 28(23):2266-75. PubMed ID: 19421151
[TBL] [Abstract][Full Text] [Related]
11. Midkine signaling maintains the self-renewal and tumorigenic capacity of glioma initiating cells.
López-Valero I; Dávila D; González-Martínez J; Salvador-Tormo N; Lorente M; Saiz-Ladera C; Torres S; Gabicagogeascoa E; Hernández-Tiedra S; García-Taboada E; Mendiburu-Eliçabe M; Rodríguez-Fornés F; Sánchez-Domínguez R; Segovia JC; Sánchez-Gómez P; Matheu A; Sepúlveda JM; Velasco G
Theranostics; 2020; 10(11):5120-5136. PubMed ID: 32308772
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of glioma initiating cells to a monoclonal anti-EGFR antibody therapy under hypoxia.
Randriarimanana T; Chateau A; Faivre B; Pinel S; Boura C
Life Sci; 2015 Sep; 137():74-80. PubMed ID: 26239438
[TBL] [Abstract][Full Text] [Related]
13. AURKA governs self-renewal capacity in glioma-initiating cells via stabilization/activation of β-catenin/Wnt signaling.
Xia Z; Wei P; Zhang H; Ding Z; Yang L; Huang Z; Zhang N
Mol Cancer Res; 2013 Sep; 11(9):1101-11. PubMed ID: 23761169
[TBL] [Abstract][Full Text] [Related]
14. Induction of autophagy promotes differentiation of glioma-initiating cells and their radiosensitivity.
Zhuang W; Li B; Long L; Chen L; Huang Q; Liang Z
Int J Cancer; 2011 Dec; 129(11):2720-31. PubMed ID: 21384342
[TBL] [Abstract][Full Text] [Related]
15. Regulated ATF5 loss-of-function in adult mice blocks formation and causes regression/eradication of gliomas.
Arias A; Lamé MW; Santarelli L; Hen R; Greene LA; Angelastro JM
Oncogene; 2012 Feb; 31(6):739-51. PubMed ID: 21725368
[TBL] [Abstract][Full Text] [Related]
16. CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas.
Bexell D; Gunnarsson S; Siesjö P; Bengzon J; Darabi A
Int J Cancer; 2009 Jul; 125(1):15-22. PubMed ID: 19291792
[TBL] [Abstract][Full Text] [Related]
17. A high Notch pathway activation predicts response to γ secretase inhibitors in proneural subtype of glioma tumor-initiating cells.
Saito N; Fu J; Zheng S; Yao J; Wang S; Liu DD; Yuan Y; Sulman EP; Lang FF; Colman H; Verhaak RG; Yung WK; Koul D
Stem Cells; 2014 Jan; 32(1):301-12. PubMed ID: 24038660
[TBL] [Abstract][Full Text] [Related]
18. Mouse induced glioma-initiating cell models and therapeutic targets.
Kondo T
Anticancer Agents Med Chem; 2010 Jul; 10(6):471-80. PubMed ID: 20879984
[TBL] [Abstract][Full Text] [Related]
19. Autophagy suppresses self-renewal ability and tumorigenicity of glioma-initiating cells and promotes Notch1 degradation.
Tao Z; Li T; Ma H; Yang Y; Zhang C; Hai L; Liu P; Yuan F; Li J; Yi L; Tong L; Wang Y; Xie Y; Ming H; Yu S; Yang X
Cell Death Dis; 2018 Oct; 9(11):1063. PubMed ID: 30337536
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk between glioma-initiating cells and endothelial cells drives tumor progression.
Jeon HM; Kim SH; Jin X; Park JB; Kim SH; Joshi K; Nakano I; Kim H
Cancer Res; 2014 Aug; 74(16):4482-92. PubMed ID: 24962027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
